154 related articles for article (PubMed ID: 35120281)
21. HLA class II alleles in Japanese patients with inflammatory bowel disease.
Yoshitake S; Kimura A; Okada M; Yao T; Sasazuki T
Tissue Antigens; 1999 Apr; 53(4 Pt 1):350-8. PubMed ID: 10323339
[TBL] [Abstract][Full Text] [Related]
22. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis.
Goyette P; Boucher G; Mallon D; Ellinghaus E; Jostins L; Huang H; Ripke S; Gusareva ES; Annese V; Hauser SL; Oksenberg JR; Thomsen I; Leslie S; ; ; ; ; ; ; ; ; Daly MJ; Van Steen K; Duerr RH; Barrett JC; McGovern DP; Schumm LP; Traherne JA; Carrington MN; Kosmoliaptsis V; Karlsen TH; Franke A; Rioux JD
Nat Genet; 2015 Feb; 47(2):172-9. PubMed ID: 25559196
[TBL] [Abstract][Full Text] [Related]
23. Pancreatitis in inflammatory bowel diseases.
Pitchumoni CS; Rubin A; Das K
J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
[TBL] [Abstract][Full Text] [Related]
24. Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians.
Khdair SI; Jarrar W; Jarrar YB; Bataineh S; Al-Khaldi O
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):895-902. PubMed ID: 31742498
[TBL] [Abstract][Full Text] [Related]
25. HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia.
Kutszegi N; Yang X; Gézsi A; Schermann G; Erdélyi DJ; Semsei ÁF; Gábor KM; Sági JC; Kovács GT; Falus A; Zhang H; Szalai C
Haematologica; 2017 Sep; 102(9):1578-1586. PubMed ID: 28596278
[TBL] [Abstract][Full Text] [Related]
26. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
Bermejo F; Lopez-Sanroman A; Taxonera C; Gisbert JP; Pérez-Calle JL; Vera I; Menchén L; Martín-Arranz MD; Opio V; Carneros JA; Van-Domselaar M; Mendoza JL; Luna M; López P; Calvo M; Algaba A
Aliment Pharmacol Ther; 2008 Sep; 28(5):623-8. PubMed ID: 18513380
[TBL] [Abstract][Full Text] [Related]
27. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany.
Reinshagen M; Loeliger C; Kuehnl P; Weiss U; Manfras BJ; Adler G; Boehm BO
Gut; 1996 Apr; 38(4):538-42. PubMed ID: 8707084
[TBL] [Abstract][Full Text] [Related]
28. Letter: predicting azathioprine-associated pancreatitis in IBD-phenotype or genotype?
Teich N; Bruns T; Stallmach A
Aliment Pharmacol Ther; 2018 Apr; 47(7):1042-1043. PubMed ID: 29512918
[No Abstract] [Full Text] [Related]
29. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
[TBL] [Abstract][Full Text] [Related]
30. Familial occurrence and inheritance studies in inflammatory bowel disease.
Binder V; Orholm M
Neth J Med; 1996 Feb; 48(2):53-6. PubMed ID: 8819799
[TBL] [Abstract][Full Text] [Related]
31. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
32. HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer.
Mahmoodi M; Nahvi H; Mahmoudi M; Kasaian A; Mohagheghi MA; Divsalar K; Nahavandian B; Jafari A; Ansarpour B; Moradi B; Aghamohammadi A; Amirzargar A
Pathol Oncol Res; 2012 Jan; 18(1):49-55. PubMed ID: 21720852
[TBL] [Abstract][Full Text] [Related]
33. [Acute azathioprine-induced pancreatitis in a female patient with Crohn's disease].
Velicia MR; González JM; Fernández P; Remacha B; Martín MA; Sánchez G; Goyeneche ML; Caro-Paton A
Gastroenterol Hepatol; 1999 Apr; 22(4):186-7. PubMed ID: 10349790
[TBL] [Abstract][Full Text] [Related]
34. Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population.
Ehsan S; Amirzargar A; Yekaninejad MS; Mahmoudi M; Mehravar S; Moradi B; Nafissi S
J Neurol Sci; 2015 Dec; 359(1-2):335-42. PubMed ID: 26671138
[TBL] [Abstract][Full Text] [Related]
35. HLA-DQA1, DQB1 and DRB1 alleles associated with Takayasu arteritis in the Chinese Han population.
Lv N; Wang Z; Dang A; Zhu X; Liu Y; Zheng D; Liu G
Hum Immunol; 2015 Apr; 76(4):241-4. PubMed ID: 25636572
[TBL] [Abstract][Full Text] [Related]
36. [Study on the correlation between chronic asymptomatic HBV carriers of yin asthenia constitution and genotypes of HLA-DRB1 and HLA DQA1 alleles].
Guo JC; Xiao LN; Xun YH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Aug; 32(8):1038-41. PubMed ID: 23173248
[TBL] [Abstract][Full Text] [Related]
37. Drug-induced acute pancreatitis due to medications used for inflammatory bowel disease: A VigiBase pharmacovigilance database study.
Lee AA; Gupta S; Labban M; Cao FT; Trinh QD; McNabb-Baltar J
Pancreatology; 2023 Sep; 23(6):569-573. PubMed ID: 37302896
[TBL] [Abstract][Full Text] [Related]
38. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
Montenegro ML; Corral JE; Lukens FJ; Ji B; Kröner PT; Farraye FA; Bi Y
Dig Dis Sci; 2022 Feb; 67(2):423-436. PubMed ID: 33625614
[TBL] [Abstract][Full Text] [Related]
40. HLA-DRB1, -DQA1 and -DQB1 genotyping of 180 Czech individuals from the Czech Republic pop 3.
Zajacova M; Kotrbova-Kozak A; Cerna M
Hum Immunol; 2016 Apr; 77(4):365-6. PubMed ID: 26867812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
